NPPB and hydrops fetalis: Additionally, NT-proBNP was confirmed to have prognostic value in the intervention group, with lower NT-proBNP levels associated with a lower risk of subsequent cardiovascular death or HF hospitalization, demonstrating how NT-proBNP concentration after empagliflozin introduction better predicts prognosis than NT-proBNP value at baseline [62].